Back to Peptide Pedia
Immune & Vitality
Well Researched

LL-37

LL-37

Antimicrobial host-defense peptide.

Also known as: Cathelicidin, L-37

Research dose range100–500 mcg (research models)
Route studiedSubcutaneous / topical
Study durationPer research protocol
Storage2–8 °C reconstituted

Overview

LL-37 is the only human cathelicidin antimicrobial peptide, studied extensively in innate-immunity, wound-healing, and host-defense research.

Key research findings

The only human cathelicidin antimicrobial peptide, studied for broad-spectrum activity against bacteria, fungi, and viruses, plus roles in wound healing and immune modulation. A key effector of innate host defense.

Mechanism of action

Disrupts microbial membranes and modulates immune signaling, chemotaxis, and angiogenesis as a host-defense peptide.

Molecular information

Weight~4,493 Da
Length37 amino acids
TypeCathelicidin antimicrobial peptide
Amino-acid sequenceLLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES

Cleaved from the hCAP18 precursor; amphipathic helix disrupts microbial membranes.

Pharmacokinetics

Peak: ~1 hourHalf-life: ~Short (local activity)Cleared: ~24 hours
Peak · 1hHalf-life · 5h

Illustrative relative-concentration model derived from published pharmacokinetic research. Curve is normalized and provided for educational comparison only — not a dosing schedule.

Research applications

  • Innate-immunity research
  • Antimicrobial studies
  • Wound-healing investigations

Research protocols

Protocols summarized from published research models. Provided for scientific reference only — not dosing guidance for human use.

Systemic referenceAmount: 100–500 mcgFrequency: Per protocolRoute: Subcutaneous
Localized referenceAmount: Per formulationFrequency: Per protocolRoute: Topical

Observed effects timeline

Aggregated observations reported across research literature. Timing and magnitude vary by model and are not a guarantee of outcome.

  1. Acute

    Direct antimicrobial membrane disruption reported in study models.

  2. Ongoing

    Wound-healing and immune-modulating signaling reported with repeated exposure.

Research compatibility

Describes how compounds are studied alongside one another in the literature. Not a recommendation to co-administer.

KPV

Complementary anti-inflammatory/host-defense pathways.

Compatible

Thymosin Alpha-1

Distinct immune-modulating mechanisms.

Compatible

Thymulin

Complementary immune signaling.

Compatible

How to reconstitute

Important

Reconstitute with bacteriostatic water, swirl gently, and refrigerate. Avoid shaking to preserve the peptide.

  1. 1Allow the vial to reach room temperature (15–20 minutes).
  2. 2Swab the stopper with alcohol and let it air dry.
  3. 3Add bacteriostatic water slowly down the vial wall.
  4. 4Swirl gently until dissolved into a clear solution.
  5. 5Refrigerate at 2–8 °C and protect from light.
Open reconstitution calculator

Quality indicators

Uniform white powder

Lyophilized cake should be white to off-white without discoloration.

Clear solution

Reconstitutes to a clear, colorless, particle-free solution.

Cold-chain integrity

Reconstituted solution requires 2–8 °C storage.

Slight clumping

Small clumps that dissolve completely with gentle swirling are acceptable — shipping can cause minor compaction.

Collapsed or melted appearance

Powder that looks collapsed, melted, or stuck to the vial walls may have been exposed to heat in transit.

Cloudy after reconstitution

Persistent cloudiness, particles, or precipitate after gentle mixing can indicate a degraded or contaminated peptide.

Reported observations & safety

Safety signals reported in the research literature. Compiled for scientific awareness — not medical advice.

  • Local injection-site reactions are commonly reported, related to its membrane-active nature.
  • Pro-inflammatory effects at higher concentrations are noted in the literature — dose context matters.

References & further reading

LL-37 cathelicidin in innate immunity (review)

Preclinical/humanantimicrobialhost defense

Review of LL-37's antimicrobial, wound-healing, and immunomodulatory roles in human innate immunity.

View study

Topics

antimicrobialimmunehost defense

This entry is provided for educational and informational purposes only. It is not medical advice, a dosing protocol, or a claim of therapeutic benefit. Research compounds are supplied strictly for laboratory and research use — not for human or veterinary consumption.

Research level
Well Researched

Substantial peer-reviewed research across multiple models.

Quick reference
Dose range100–500 mcg (research models)
RouteSubcutaneous / topical
DurationPer research protocol
Storage2–8 °C reconstituted
Half-life~Short (local activity)
Catalogue status

This compound is part of our educational reference and is not currently stocked. Browse the catalogue for available research-grade peptides.

Browse catalogue